Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Equity Ratio (2020 - 2025)

RxSight's Equity Ratio history spans 6 years, with the latest figure at 0.88 for Q4 2025.

  • For Q4 2025, Equity Ratio changed 0.15% year-over-year to 0.88; the TTM value through Dec 2025 reached 0.88, changed 0.15%, while the annual FY2025 figure was 0.88, 0.15% changed from the prior year.
  • Equity Ratio reached 0.88 in Q4 2025 per RXST's latest filing, down from 0.89 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.9 in Q2 2024 to a low of 3.3 in Q2 2021.
  • Average Equity Ratio over 5 years is 0.59, with a median of 0.88 recorded in 2023.
  • The largest YoY upside for Equity Ratio was 119.97% in 2022 against a maximum downside of 16.79% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.72 in 2021, then dropped by 16.54% to 0.6 in 2022, then surged by 46.73% to 0.88 in 2023, then rose by 0.5% to 0.88 in 2024, then increased by 0.15% to 0.88 in 2025.
  • Per Business Quant, the three most recent readings for RXST's Equity Ratio are 0.88 (Q4 2025), 0.89 (Q3 2025), and 0.9 (Q2 2025).